In this study, we identified galectin-1, alpha-1-microglobulin, and galectin-9 as the immunomodulatory proteins that are independently associated with 2-year MACE in patients with PAD, thereby acting as potential prognostic biomarkers. The gene discussed is LGALS9; the disease is peripheral arterial disease.